186 related articles for article (PubMed ID: 34388295)
1. Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity.
Teyateeti A; Grossman C; Kollmeier MA; Fiasconaro M; Hopkins M; McBride S; Gorovets D; Shasha D; Cohen G; Zhang Z; Lesser DJ; Damato A; Zelefsky MJ
BJU Int; 2022 Mar; 129(3):337-344. PubMed ID: 34388295
[TBL] [Abstract][Full Text] [Related]
2. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
[TBL] [Abstract][Full Text] [Related]
3. The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapy.
Nehlsen AD; Sindhu KK; Moshier E; Sfakianos JP; Stock RG
Brachytherapy; 2021; 20(2):296-301. PubMed ID: 33199175
[TBL] [Abstract][Full Text] [Related]
4. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL
Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584
[TBL] [Abstract][Full Text] [Related]
5. Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.
Kahn J; Dahman B; McLaughlin C; Kapoor P; Kapoor R; Harris E; Sharma M; Schutzer M; Moghanaki D
Brachytherapy; 2020; 19(2):228-233. PubMed ID: 32085930
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.
Yeh J; Lehrich B; Tran C; Mesa A; Baghdassarian R; Yoshida J; Torrey R; Gazzaniga M; Weinberg A; Chalfin S; Ravera J; Tokita K
Brachytherapy; 2016; 15(3):283-287. PubMed ID: 26853354
[TBL] [Abstract][Full Text] [Related]
7. Cs-131 prostate brachytherapy boost and effect of hydrogel rectal spacer on long-term patient-reported rectal bleeding and bowel quality of life.
Abdelhakiem MK; Keller A; Bajpai RR; Smith RP; Beriwal S; Benoit R
Brachytherapy; 2023; 22(6):808-821. PubMed ID: 37648596
[TBL] [Abstract][Full Text] [Related]
8. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.
Wu SY; Boreta L; Wu A; Cheung JP; Cunha JAM; Shinohara K; Chang AJ
Brachytherapy; 2018; 17(2):259-264. PubMed ID: 29203149
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of late rectal toxicity in prostate cancer patients treated with low-dose-rate brachytherapy: With or without supplemental external beam radiotherapy.
Serrano N; Moghanaki D; Asher D; Karlin J; Schutzer M; Chang M; Hagan MP
Brachytherapy; 2016; 15(4):435-441. PubMed ID: 27180124
[TBL] [Abstract][Full Text] [Related]
10. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study.
Dinh TT; Lee HJ; Macomber MW; Apisarnthanarax S; Zeng J; Laramore GE; Rengan R; Russell KJ; Chen JJ; Ellis WJ; Schade GR; Liao JJ
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):635-643. PubMed ID: 32035187
[TBL] [Abstract][Full Text] [Related]
11. Placement of SpaceOAR hydrogel spacer for prostate cancer patients treated with iodine-125 low-dose-rate brachytherapy.
Morita M; Fukagai T; Hirayama K; Yamatoya J; Noguchi T; Ogawa Y; Igarashi A; Niiya A; Kato M; Morota M; Oshinomi K; Ogawa Y; Lederer JL
Int J Urol; 2020 Jan; 27(1):60-66. PubMed ID: 31587417
[TBL] [Abstract][Full Text] [Related]
12. Biological effective dose in analysis of rectal dose in prostate cancer patients who underwent a combination therapy of VMAT and LDR with hydrogel spacer insertion.
Zhang H; Wang L; Riegel AC; Antone J; Potters L; Lee L; Cao Y
J Appl Clin Med Phys; 2022 Jun; 23(6):e13584. PubMed ID: 35285578
[TBL] [Abstract][Full Text] [Related]
13. Rectal sparing in prostate radiotherapy with combination-brachytherapy and hydrogel spacer.
Cousins MM; Heckman P; Short E; Narayana V; Bryant AK; Evans C; Hixson G; Hurley P; McLaughlin PW
Brachytherapy; 2022; 21(3):300-307. PubMed ID: 35125329
[TBL] [Abstract][Full Text] [Related]
14. Incidence and dosimetric predictive factors of late rectal toxicity after low-dose-rate brachytherapy combined with volumetric modulated arc therapy in high-risk prostate cancer at a single institution: Retrospective study.
Sakurai T; Takamatsu S; Shibata S; Taka M; Ishiyama M; Yamazaki M; Kojima H; Mizokami A; Kumano T; Gabata T
Brachytherapy; 2021; 20(3):584-594. PubMed ID: 33485811
[TBL] [Abstract][Full Text] [Related]
15. Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR.
Patel AK; Houser C; Benoit R; Smith RP; Beriwal S
Brachytherapy; 2020; 19(4):477-483. PubMed ID: 32331976
[TBL] [Abstract][Full Text] [Related]
16. Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique.
Vaggers S; Rai BP; Chedgy ECP; de la Taille A; Somani BK
World J Urol; 2021 Jun; 39(6):1769-1780. PubMed ID: 32840655
[TBL] [Abstract][Full Text] [Related]
17. Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: A systematic review.
Afkhami Ardekani M; Ghaffari H
Brachytherapy; 2020; 19(1):13-23. PubMed ID: 31542390
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patients.
Tanaka T; Yorozu A; Sutani S; Yagi Y; Nishiyama T; Shiraishi Y; Ohashi T; Hanada T; Saito S; Toya K; Shigematsu N
Brachytherapy; 2018; 17(5):799-807. PubMed ID: 29936128
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.
Sakurai T; Takamatsu S; Shibata S; Iwata K; Taka M; Gabata T; Kumano T; Makino T; Mizokami A
Jpn J Radiol; 2020 Dec; 38(12):1197-1208. PubMed ID: 32737768
[TBL] [Abstract][Full Text] [Related]
20. Hydrogel spacer shrinkage during external-beam radiation therapy following low-dose-rate brachytherapy for high-risk prostate cancer: a case series.
Kubo K; Kenjo M; Kawabata H; Wadasaki K; Kajiwara M; Doi Y; Nakao M; Miura H; Ozawa S; Nagata Y
J Med Case Rep; 2021 May; 15(1):296. PubMed ID: 34034804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
